{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:13:28Z","timestamp":1792790008727,"version":"4.5.0"},"reference-count":234,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH AID","award":["AI171292"],"award-info":[{"award-number":["AI171292"]}]},{"name":"NIH AID","award":["AI106695"],"award-info":[{"award-number":["AI106695"]}]},{"name":"NIH AID","award":["AI181960"],"award-info":[{"award-number":["AI181960"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Flaviviruses are arthropod-borne viruses primarily transmitted through the mosquito Aedes aegypti or Culex genus of mosquitos. These viruses are predominantly found in tropical and subtropical regions of the world with their geographical spread predicted to increase as global temperatures continue to rise. These viruses cause a variety of diseases in humans with the most prevalent being caused by dengue, resulting in hemorrhagic fever and associated sequala. Current approaches for therapeutic control of flavivirus infections are limited, and despite recent advances, there are no approved drugs. Vaccines, available for a few circulating flaviviruses, still have limited potential for controlling contemporary and future outbreaks. Mouse models provide us with a valuable tool to test the effectiveness of drugs and vaccines, yet for many flaviviruses, well-established mouse models are lacking. In this review, we highlight the current state of flavivirus vaccines and therapeutics, as well as our current understanding of mouse models for various flaviviruses.<\/jats:p>","DOI":"10.3390\/v17010001","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T02:50:56Z","timestamp":1735008656000},"page":"1","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses"],"prefix":"10.3390","volume":"17","author":[{"given":"Thomas J.","family":"Baric","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3500, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-000X","authenticated-orcid":false,"given":"Z. Beau","family":"Reneer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3500, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100712","DOI":"10.1016\/j.eclinm.2020.100712","article-title":"Global, Regional, and National Dengue Burden from 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017","volume":"32","author":"Zeng","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The Global Distribution and Burden of Dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref_3","unstructured":"(2024, October 09). Harry Stevens Where Mosquito Season Is Getting Longer. Available online: https:\/\/www.washingtonpost.com\/climate-environment\/interactive\/2024\/mosquito-season-state-change-global-warming\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13744-017-0520-4","article-title":"Why Is Aedes Aegypti Linnaeus so Successful as a Species?","volume":"46","author":"Carvalho","year":"2017","journal-title":"Neotrop. Entomol."},{"key":"ref_5","unstructured":"World Health Organization (2009). Dengue Guidelines for Diagnosis, Treatment, Prevention and Control Treatment, Prevention and Control Treatment, Prevention and Control, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2020.01.015","article-title":"Zika Virus-Spread, Epidemiology, Genome, Transmission Cycle, Clinical Manifestation, Associated Challenges, Vaccine and Antiviral Drug Development","volume":"543","author":"Pielnaa","year":"2020","journal-title":"Virology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/v6020606","article-title":"Clinical Manifestations and Outcomes of West Nile Virus Infection","volume":"6","author":"Sejvar","year":"2014","journal-title":"Viruses"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","article-title":"Japanese Encephalitis-the Prospects for New Treatments","volume":"14","author":"Turtle","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Pustijanac, E., Bur\u0161i\u0107, M., Talapko, J., \u0160krlec, I., Me\u0161trovi\u0107, T., and Li\u0161nji\u0107, D. (2023). Tick-Borne Encephalitis Virus: A Comprehensive Review of Transmission, Pathogenesis, Epidemiology, Clinical Manifestations, Diagnosis, and Prevention. Microorganisms, 11.","DOI":"10.3390\/microorganisms11071634"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-Enhanced Dengue Virus Infection in Primate Leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e05407","DOI":"10.1016\/j.heliyon.2020.e05407","article-title":"Dengue Virus Susceptibility in Novel Immortalized Myeloid Cells","volume":"6","author":"Yamanaka","year":"2020","journal-title":"Heliyon"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1089\/vbz.2013.1528","article-title":"An Estimate of the Global Health Care and Lost Productivity Costs of Dengue","volume":"14","author":"Selck","year":"2014","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hung, T.M., Shepard, D.S., Bettis, A.A., Nguyen, H.A., McBride, A., Clapham, H.E., and Turner, H.C. (2020). Productivity Costs from a Dengue Episode in Asia: A Systematic Literature Review. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05109-0"},{"key":"ref_14","unstructured":"S\u00e1nchez-Gonz\u00e1lez, L., Adams, L., and Paz-Bailey, G. (2024, October 27). Dengue, Available online: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/infections-diseases\/dengue."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e016805","DOI":"10.1136\/bmjopen-2017-016805","article-title":"Determinants of Mortality and Prolonged Hospital Stay among Dengue Patients Attending Tertiary Care Hospital: A Cross-Sectional Retrospective Analysis","volume":"7","author":"Mallhi","year":"2017","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Brady, O.J., Gething, P.W., Bhatt, S., Messina, J.P., Brownstein, J.S., Hoen, A.G., Moyes, C.L., Farlow, A.W., Scott, T.W., and Hay, S.I. (2012). Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001760"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMra1808246","article-title":"Zika Virus Infection\u2014After the Pandemic","volume":"381","author":"Musso","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Costa, M.C.N., Cardim, L.L., Teixeira, M.G., Barreto, M.L., Carvalho-Sauer, R.d.C.O.d., Barreto, F.R., Carvalho, M.S.I., Oliveira, W.K., Fran\u00e7a, G.V.A., and Carmo, E.H. (2020). Case Fatality Rate Related to Microcephaly Congenital Zika Syndrome and Associated Factors: A Nationwide Retrospective Study in Brazil. Viruses, 12.","DOI":"10.3390\/v12111228"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sejvar, J.J. (2016). West Nile Virus Infection. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.EI10-0021-2016"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","article-title":"West Nile Virus","volume":"2","author":"Campbell","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","unstructured":"Simon, L.V., Sandhu, D.S., Goyal, A., and Kruse, B. (2024). Japanese Encephalitis. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_22","unstructured":"Hills, S., Lindsey, N., and Fischer, M. (2024, October 27). Japanese Encephalitis, Available online: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/infections-diseases\/japanese-encephalitis#:~:text=Seizures%20are%20common%2C%20especially%20among,%2C%20moderate%20leukocytosis%2C%20and%20hyponatremia."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Phipps, L.P., and Johnson, N. (2022). Tick-Borne Encephalitis Virus. J. Med. Microbiol., 71.","DOI":"10.1099\/jmm.0.001492"},{"key":"ref_24","unstructured":"Cohen, M.K., Muntner, P., Kent, C.K., Gottardy, A.J., Leahy, M.A., Spriggs, S.R., Velarde, A., Yang, T., Doan, Q.M., and King, P.H. (2023). Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023, Morbidity and Mortality Weekly Report."},{"key":"ref_25","unstructured":"(2024, October 27). Tick-Borne Encephalitis. Available online: https:\/\/www.who.int\/health-topics\/tick-borne-encephalitis#tab=tab_2."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cld.784","article-title":"An Official Learning Resource of AASLD Review: Acute Liver Failure Secondary to Yellow Fever: A Challenging Scenario","volume":"13","author":"Song","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"ref_27","unstructured":"(2024, October 27). Yellow Fever. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever."},{"key":"ref_28","first-page":"369","article-title":"Safety of Dengue Vaccine?","volume":"76","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JVI.76.11.5480-5491.2002","article-title":"Folding and Dimerization of Tick-Borne Encephalitis Virus Envelope Proteins PrM and E in the Endoplasmic Reticulum","volume":"76","author":"Lorenz","year":"2002","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of Immature Flavivirus Particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of Dengue Virus: Implications for Flavivirus Organization, Maturation, and Fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-virology-110615-042334","article-title":"Properties and Functions of the Dengue Virus Capsid Protein","volume":"3","author":"Byk","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcv.2012.08.024","article-title":"Flaviviruses and their antigenic structure","volume":"55","author":"Heinz","year":"2012","journal-title":"J. Clin. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the Dengue Virus Envelope Protein after Membrane Fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM Structure of the Mature Dengue Virus at 3.5-\u00c5 Resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gallichotte, E.N., Baric, T.J., Yount, B.L., Widman, D.G., Durbin, A., Whitehead, S., Baric, R.S., and de Silva, A.M. (2018). Human Dengue Virus Serotype 2 Neutralizing Antibodies Target Two Distinct Quaternary Epitopes. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006934"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3","volume":"84","author":"Brien","year":"2010","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The Flavivirus NS1 Protein: Molecular and Structural Biology, Immunology, Role in Pathogenesis and Application as a Diagnostic Biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1128\/JVI.00157-12","article-title":"Evidence for a Genetic and Physical Interaction between Nonstructural Proteins NS1 and NS4B That Modulates Replication of West Nile Virus","volume":"86","author":"Youn","year":"2012","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1099\/jgv.0.001462","article-title":"Mutations in the Cytoplasmic Domain of Dengue Virus NS4A Affect Virus Fitness and Interactions with Other Non-Structural Proteins","volume":"101","author":"Tan","year":"2020","journal-title":"J. Gen. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism Conceived and Designed the Experiments","volume":"26","author":"Glasner","year":"2019","journal-title":"Cell Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wang, C., Puerta-Guardo, H., Biering, S.B., Glasner, D.R., Tran, E.B., Patana, M., Gomberg, T.A., Malvar, C., Lo, N.T.N., and Espinosa, D.A. (2019). Endocytosis of Flavivirus NS1 Is Required for NS1-Mediated Endothelial Hyperpermeability and Is Abolished by a Single N-Glycosylation Site Mutation. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007938"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20092545","article-title":"Antagonism of the Complement Component C4 by Flavivirus Nonstructural Protein NS1","volume":"207","author":"Avirutnan","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Carpio, K.L., and Barrett, A.D.T. (2021). Flavivirus Ns1 and Its Potential in Vaccine Development. Vaccines, 9.","DOI":"10.3390\/vaccines9060622"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Dubrau, D., Tortorici, M.A., Rey, F.A., and Tautz, N. (2017). A Positive-Strand RNA Virus Uses Alternative Protein-Protein Interactions within a Viral Protease\/Cofactor Complex to Switch between RNA Replication and Virion Morphogenesis. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006134"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JVI.01788-07","article-title":"Crystal Structure of the NS3 Protease-Helicase from Dengue Virus","volume":"82","author":"Luo","year":"2008","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wahaab, A., Liu, K., Hameed, M., Anwar, M.N., Kang, L., Li, C., Ma, X., Wajid, A., Yang, Y., and Khan, U.H. (2021). Identification of Cleavage Sites Proteolytically Processed by Ns2b-Ns3 Protease in Polyprotein of Japanese Encephalitis Virus. Pathogens, 10.","DOI":"10.3390\/pathogens10020102"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3\u2013NS4B Interaction Inhibits Dengue Virus in Non-Human Primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Biswal, M., Yao, W., Lu, J., Chen, J., Morrison, J., Hai, R., and Song, J. (2024). A Conformational Selection Mechanism of Flavivirus NS5 for Species-Specific STAT2 Inhibition. Commun. Biol., 7.","DOI":"10.1038\/s42003-024-05768-8"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.str.2024.04.020","article-title":"Structural and Functional Insights in Flavivirus NS5 Proteins Gained by the Structure of Ntaya Virus Polymerase and Methyltransferase","volume":"32","author":"Krafcikova","year":"2024","journal-title":"Structure"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.80.9.4623-4632.2006","article-title":"Regulated Cleavages at the West Nile Virus NS4A-2K-NS4B Junctions Play a Major Role in Rearranging Cytoplasmic Membranes and Golgi Trafficking of the NS4A Protein","volume":"80","author":"Roosendaal","year":"2006","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11274","DOI":"10.1128\/JVI.05864-11","article-title":"A Conserved Peptide in West Nile Virus NS4A Protein Contributes to Proteolytic Processing and Is Essential for Replication","volume":"85","author":"Ambrose","year":"2011","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of Interferon Signaling by Dengue Virus","volume":"100","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/JVI.02050-10","article-title":"West Nile Virus Differentially Modulates the Unfolded Protein Response to Facilitate Replication and Immune Evasion","volume":"85","author":"Ambrose","year":"2011","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Klaitong, P., and Smith, D.R. (2021). Roles of Non-Structural Protein 4a in Flavivirus Infection. Viruses, 13.","DOI":"10.3390\/v13102077"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Dos Reis, V.P., Keller, M., Schmidt, K., Ulrich, R.G., and Groschup, M.H. (2022). AV\u03b23 Integrin Expression Is Essential for Replication of Mosquito and Tick-Borne Flaviviruses in Murine Fibroblast Cells. Viruses, 14.","DOI":"10.3390\/v14010018"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/v3020160","article-title":"Flavivirus Cell Entry and Membrane Fusion","volume":"3","author":"Smit","year":"2011","journal-title":"Viruses"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.meegid.2019.01.018","article-title":"ZIKA Virus Entry Mechanisms in Human Cells","volume":"69","author":"Agrelli","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Laureti, M., Narayanan, D., Rodriguez-Andres, J., Fazakerley, J.K., and Kedzierski, L. (2018). Flavivirus Receptors: Diversity, Identity, and Cell Entry. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02180"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/viro.2001.1232","article-title":"Heparan Sulfate-Mediated Binding of Infectious Dengue Virus Type 2 and Yellow Fever Virus","volume":"292","author":"Germi","year":"2002","journal-title":"Virology"},{"key":"ref_61","first-page":"866","article-title":"Dengue Virus Infectivity Depends on Envelope Protein Binding to Target Cell Heparan Sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1128\/JVI.72.9.7357-7366.1998","article-title":"Adaptation of Sindbis Virus to BHK Cells Selects for Use of Heparan Sulfate as an Attachment Receptor","volume":"72","author":"Klimstra","year":"1998","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2004.05.124","article-title":"Identification of a 48 KDa Tubulin or Tubulin-like C6\/36 Mosquito Cells Protein That Binds Dengue Virus 2 Using Mass Spectrometry","volume":"320","author":"Chee","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00705-012-1596-0","article-title":"Surface Proteins of C6\/36 Cells Involved in Dengue Virus 4 Binding and Entry","volume":"158","year":"2013","journal-title":"Arch. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.embor.embor866","article-title":"Dendritic-Cell-Specific ICAM3-Grabbing Non-Integrin Is Essential for the Productive Infection of Human Dendritic Cells by Mosquito-Cell-Derived Dengue Viruses","volume":"4","author":"Altmeyer","year":"2003","journal-title":"EMBO Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jviromet.2003.10.014","article-title":"Isolation of Putative Dengue Virus Receptor Molecules by Affinity Chromatography Using a Recombinant E Protein Ligand","volume":"116","author":"Valle","year":"2004","journal-title":"J. Virol. Methods"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1128\/jvi.71.10.7246-7252.1997","article-title":"Identification of Two Surface Proteins from C6 \/ 36 Cells That Bind Dengue Type 4 Virus","volume":"71","author":"Rosa","year":"1997","journal-title":"J. Virol."},{"key":"ref_68","first-page":"1102","article-title":"Antibody Fucosylation Predicts Disease Severity in Secondary Dengue Infection HHS Public Access","volume":"372","author":"Bournazos","year":"2021","journal-title":"Science (1979)"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-Stimulated Genes: A Complex Web of Host Defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The Interferons and Their Receptors-Distribution and Regulation","volume":"90","author":"Nguyen","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature09489","article-title":"2\u2032-O Methylation of the Viral MRNA Cap Evades Host Restriction by IFIT Family Members","volume":"468","author":"Daffis","year":"2010","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri3344","article-title":"The Broad-Spectrum Antiviral Functions of IFIT and IFITM Proteins","volume":"13","author":"Diamond","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of Alpha\/Beta Interferon Signaling by the NS4B Protein of Flaviviruses","volume":"79","author":"Ashour","year":"2005","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JVI.79.3.1934-1942.2005","article-title":"Inhibition of Interferon Signaling by the New York 99 Strain and Kunjin Subtype of West Nile Virus Involves Blockage of STAT1 and STAT2 Activation by Nonstructural Proteins","volume":"79","author":"Liu","year":"2005","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e01970-16","DOI":"10.1128\/JVI.01970-16","article-title":"The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling","volume":"91","author":"Best","year":"2017","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2017.05.146","article-title":"Antagonism of Type I Interferon by Flaviviruses","volume":"492","author":"Miorin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-9086-3_1","article-title":"The Applicability of Mouse Models to the Study of Human Disease","volume":"Volume 1940","author":"Johnson","year":"2019","journal-title":"Mouse Cell Culture"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.017420","article-title":"West Nile Virus Infection in the Golden Hamster (Mesocricetus Auratus): A Model for West Nile Encephalitis","volume":"7","author":"Xiao","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1099\/vir.0.063537-0","article-title":"Evaluation of a Mouse Model for the West Nile Virus Group for the Purpose of Determining Viral Pathotypes","volume":"95","author":"Bingham","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Graham, J.B., Swarts, J.L., Wilkins, C., Thomas, S., Green, R., Sekine, A., Voss, K.M., Ireton, R.C., Mooney, M., and Choonoo, G. (2016). A Mouse Model of Chronic West Nile Virus Disease. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005996"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/jvi.70.7.4761-4766.1996","article-title":"Phenotypic Changes in Langerhans\u2019 Cells after Infection with Arboviruses: A Role in the Immune Response to Epidermally Acquired Viral Infection?","volume":"70","author":"Johnston","year":"1996","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4939-3670-0_6","article-title":"Lessons from the Murine Models of West Nile Virus Infection","volume":"Volume 1435","author":"McGruder","year":"2016","journal-title":"West Nile Virus"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5858\/2004-128-533-SCNIHW","article-title":"Spinal Cord Neuropathology in Human West Nile Virus Infection","volume":"128","author":"Fratkin","year":"2004","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2001.tb02687.x","article-title":"West Nile Virus Infection in Birds and Mammals","volume":"951","author":"Kramer","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1084\/jem.20090222","article-title":"Key Role of T Cell Defects in Age-Related Vulnerability to West Nile Virus","volume":"206","author":"Brien","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","article-title":"The outbreak of West Nile virus infection in the New York city area in 1999","volume":"344","author":"Enis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1128\/JVI.00918-08","article-title":"Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus Infection","volume":"82","author":"Daffis","year":"2008","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cpmo.33","article-title":"A Mouse Model of West Nile Virus Infection","volume":"7","author":"Graham","year":"2017","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/Beta Interferon Protects against Lethal West Nile Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal Survival","volume":"79","author":"Samuel","year":"2005","journal-title":"J. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tig.2018.07.005","article-title":"Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections","volume":"34","author":"Leist","year":"2018","journal-title":"Trends Genet."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer, A., Leist, S.R., Gralinski, L.E., Martinez, D.R., Winkler, E.S., Okuda, K., Hawkins, P.E., Gully, K.L., Graham, R.L., and Scobey, D.T. (2022). A Multitrait Locus Regulates Sarbecovirus Pathogenesis. mBio, 13.","DOI":"10.1128\/mbio.01454-22"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e00493-15.","DOI":"10.1128\/mBio.00493-15","article-title":"Genetic Diversity in the Collaborative Cross Model Recapitulates Human West Nile Virus Disease Outcomes","volume":"6","author":"Graham","year":"2015","journal-title":"mBio"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gdata.2016.10.006","article-title":"Identifying Protective Host Gene Expression Signatures within the Spleen during West Nile Virus Infection in the Collaborative Cross Model","volume":"10","author":"Green","year":"2016","journal-title":"Genom. Data"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/infdis\/jiy623","article-title":"Immune Correlates of Protection from West Nile Virus Neuroinvasion and Disease","volume":"219","author":"Graham","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"J\u00e1come, F.C., Caldas, G.C., Rasinhas, A.d.C., de Almeida, A.L.T., de Souza, D.D.C., Paulino, A.C., da Silva, M.A.N., Bandeira, D.M., Barth, O.M., and dos Santos, F.B. (2021). Immunocompetent Mice Infected by Two Lineages of Dengue Virus Type 2: Observations on the Pathology of the Lung, Heart and Skeletal Muscle. Microorganisms, 9.","DOI":"10.3390\/microorganisms9122536"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ame2.12145","article-title":"A Murine Model of Dengue Virus Infection in Suckling C57BL\/6 and BALB\/c Mice","volume":"4","author":"Byrne","year":"2021","journal-title":"Anim. Model. Exp. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Balsitis, S.J., Williams, K.L., Lachica, R., Flores, D., Kyle, J.L., Mehlhop, E., Johnson, S., Diamond, M.S., Beatty, P.R., and Harris, E. (2010). Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000790"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Manangeeswaran, M., Ireland, D.D.C., and Verthelyi, D. (2016). Zika (PRVABC59) Infection Is Associated with T Cell Infiltration and Neurodegeneration in CNS of Immunocompetent Neonatal C57Bl\/6 Mice. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006004"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A Mouse Model of Zika Virus Pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"veaa092","DOI":"10.1093\/ve\/veaa092","article-title":"Mapping the Evolutionary Landscape of Zika Virus Infection in Immunocompromised Mice","volume":"6","author":"Johnson","year":"2020","journal-title":"Virus Evol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Winkler, C.W., Woods, T.A., Rosenke, R., Scott, D.P., Best, S.M., and Peterson, K.E. (2017). Sexual and Vertical Transmission of Zika Virus in Anti-Interferon Receptor-Treated Rag1-Deficient Mice. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-07099-7"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/JVI.01034-19","article-title":"Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b","volume":"94","author":"Manet","year":"2020","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1186\/1742-2094-10-77","article-title":"Mice with Different Susceptibility to Tick-Borne Encephalitis Virus Infection Show Selective Neutralizing Antibody Response and Inflammatory Reaction in the Central Nervous System","volume":"10","author":"Palus","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Tun, M.M.N., Aoki, K., Senba, M., Buerano, C.C., Shirai, K., Suzuki, R., Morita, K., and Hayasaka, D. (2014). Protective Role of TNF-\u03b1, IL-10 and IL-2 in Mice Infected with the Oshima Strain of Tick-Borne Encephalitis Virus. Sci. Rep., 4.","DOI":"10.1038\/srep05344"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2009.04.026","article-title":"Mortality Following Peripheral Infection with Tick-Borne Encephalitis Virus Results from a Combination of Central Nervous System Pathology, Systemic Inflammatory and Stress Responses","volume":"390","author":"Hayasaka","year":"2009","journal-title":"Virology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"dmm049176","DOI":"10.1242\/dmm.049176","article-title":"Development and Characterization of an Animalmodel of Japanese Encephalitis Virus Infection in Adolescent C57BL\/6 Mouse","volume":"14","author":"Tripathi","year":"2021","journal-title":"DMM Dis. Models Mech."},{"key":"ref_107","first-page":"349","article-title":"Pathological Findings in a Mouse Model of Japanese Encephalitis Infected via the Footpad","volume":"20","author":"Fu","year":"2015","journal-title":"Neurol. Asia"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Chai, C., Palinski, R., Xu, Y., Wang, Q., Cao, S., Geng, Y., Zhao, Q., Wen, Y., Huang, X., and Yan, Q. (2019). Aerosol and Contact Transmission Following Intranasal Infection of Mice with Japanese Encephalitis Virus. Viruses, 11.","DOI":"10.3390\/v11010087"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1099\/vir.0.000075","article-title":"Spectrum of Disease Outcomes in Mice Infected with YFV-17D","volume":"96","author":"Erickson","year":"2015","journal-title":"General. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Meier, K.C., Gardner, C.L., Khoretonenko, M.V., Klimstra, W.B., and Ryman, K.D. (2009). A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000614"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1080\/22221751.2019.1694394","article-title":"Limited Evolution of the Yellow Fever Virus 17d in a Mouse Infection Model","volume":"8","author":"Kum","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.vaccine.2012.03.003","article-title":"A Small Animal Peripheral Challenge Model of Yellow Fever Using Interferon-Receptor Deficient Mice and the 17D-204 Vaccine Strain","volume":"30","author":"Thibodeaux","year":"2012","journal-title":"Vaccine"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"da Silva, F.C., Magaldi, F.M., Sato, H.K., and Bevilacqua, E. (2020). Yellow Fever Vaccination in a Mouse Model Is Associated with Uninterrupted Pregnancies and Viable Neonates Except When Administered at Implantation Period. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00245"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","article-title":"An Immunocompetent Mouse Model of Zika Virus Infection","volume":"23","author":"Gorman","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","article-title":"Zika Virus Targets Human STAT2 to Inhibit Type i Interferon Signaling","volume":"19","author":"Grant","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain Development in Rodents and Humans: Identifying Benchmarks of Maturation and Vulnerability to Injury across Species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/imm.12883","article-title":"Using Immunocompromised Mice to Identify Mechanisms of Zika Virus Transmission and Pathogenesis _ Enhanced Reader","volume":"153","author":"Winkler","year":"2017","journal-title":"Immunology"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Counotte, M.J., Kim, C.R., Wang, J., Bernstein, K., Deal, C.D., Broutet, N.J.N., and Low, N. (2018). Sexual Transmission of Zika Virus and Other Flaviviruses: A Living Systematic Review. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002611"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Caine, E.A., Jagger, B.W., and Diamond, M.S. (2018). Animal Models of Zika Virus Infection during Pregnancy. Viruses, 10.","DOI":"10.3390\/v10110598"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.4485","article-title":"Congenital Zika Virus Infection as a Silent Pathology with Loss of Neurogenic Output in the Fetal Brain","volume":"24","author":"Nelson","year":"2018","journal-title":"Nat. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 Restricts Early Dengue Virus Replication","volume":"8","author":"Ashour","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4149\/av_2019_309","article-title":"Secondary Dengue Infection in Immunocompetent Murine Model Leads to Heart Tissue Damage","volume":"63","author":"Caldas","year":"2019","journal-title":"Acta Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41467-023-36702-x","article-title":"A Live Dengue Virus Vaccine Carrying a Chimeric Envelope Glycoprotein Elicits Dual DENV2-DENV4 Serotype-Specific Immunity","volume":"14","author":"Young","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.virol.2014.01.015","article-title":"Viral Kinetics of Primary Dengue Virus Infection in Non-Human Primates: A Systematic Review and Individual Pooled Analysis","volume":"452\u2013453","author":"Althouse","year":"2014","journal-title":"Virology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e0071523","DOI":"10.1128\/jvi.00715-23","article-title":"Neuroinvasive Flavivirus Pathogenesis Is Restricted by Host Genetic Factors in Collaborative Cross Mice, Independently of Oas1b","volume":"97","author":"Jasperse","year":"2023","journal-title":"J. Virol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/HEP.0000000000000547","article-title":"Host Genetic Variation Guides Hepacivirus Clearance, Chronicity, and Liver Fibrosis in Mice","volume":"79","author":"Brown","year":"2024","journal-title":"Hepatology"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Bharucha, T., Cleary, B., Farmiloe, A., Sutton, E., Hayati, H., Kirkwood, P., al Hamed, L., van Ginneken, N., Subramaniam, K.S., and Zitzmann, N. (2022). Mouse Models of Japanese Encephalitis Virus Infection: A Systematic Review and Metaanalysis Using a Meta-Regression Approach. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010116"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","article-title":"The Interferon Signaling Antagonist Function of Yellow Fever Virus NS5 Protein Is Activated by Type i Interferon","volume":"16","author":"Morrison","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2020.09.001","article-title":"Dengue Mouse Models for Evaluating Pathogenesis and Countermeasures","volume":"43","author":"Chen","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Da Silveira, L.T.C., Tura, B., and Santos, M. (2019). Systematic Review of Dengue Vaccine Efficacy. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4369-5"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Shukla, R., Ramasamy, V., Shanmugam, R.K., Ahuja, R., and Khanna, N. (2020). Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.572681"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"George, J., Valiant, W.G., Mattapallil, M.J., Walker, M., Huang, Y.J.S., Vanlandingham, D.L., Misamore, J., Greenhouse, J., Weiss, D.E., and Verthelyi, D. (2017). Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10901-1"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41541-022-00552-3","article-title":"Yellow Fever Resurgence: An Avoidable Crisis?","volume":"7","author":"Lindsey","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref_134","first-page":"e23951","article-title":"COVID-19 Vaccine Challenges in Developing and Developed Countries","volume":"14","author":"Yarlagadda","year":"2022","journal-title":"Cureus"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Lee, M.F., Wu, Y.S., and Poh, C.L. (2023). Molecular Mechanisms of Antiviral Agents against Dengue Virus. Viruses, 15.","DOI":"10.3390\/v15030705"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-Spectrum Agents for Flaviviral Infections: Dengue, Zika and Beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"eabo0718","DOI":"10.1126\/scitranslmed.abo0718","article-title":"Mutations in the SARS-CoV-2 RNA-Dependent RNA Polymerase Confer Resistance to Remdesivir by Distinct Mechanisms","volume":"14","author":"Stevens","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current Progress in Antiviral Strategies","volume":"35","author":"Lou","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/med.21664","article-title":"Medicinal Chemistry Strategies toward Host Targeting Antiviral Agents","volume":"40","author":"Ji","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14622416.5.6.643","article-title":"Pharmacogenetics of Antiretroviral Therapy: Genetic Variation of Response and Toxicity","volume":"5","author":"Martin","year":"2004","journal-title":"Pharmacogenomics"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/3293","article-title":"Potent Suppression of HIV-1 Replication in Humans by T-20, a Peptide Inhibitor of Gp41-Mediated Virus Entry","volume":"4","author":"Kilby","year":"1998","journal-title":"Nat. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00018-018-2751-x","article-title":"Structure and Function of Zika Virus NS5 Protein: Perspectives for Drug Design","volume":"75","author":"Wang","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2009.09.014","article-title":"Nucleoside and Nucleotide HIV Reverse Transcriptase Inhibitors: 25 Years after Zidovudine","volume":"85","author":"Cihlar","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Radoshitzky, S.R., Iversen, P., Lu, X., Zou, J., Kaptein, S.J.F., Stuthman, K.S., Van Tongeren, S.A., Steffens, J., Gong, R., and Truong, H. (2023). Expanded Profiling of Remdesivir as a Broad-Spectrum Antiviral and Low Potential for Interaction with Other Medications in Vitro. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-29517-9"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"104541","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad Spectrum Antiviral Remdesivir Inhibits Human Endemic and Zoonotic Deltacoronaviruses with a Highly Divergent RNA Dependent RNA Polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-Spectrum Antiviral GS-5734 Inhibits Both Epidemic and Zoonotic Coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/cid\/ciad284","article-title":"Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-Serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers","volume":"77","author":"Ackaert","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The Broad Spectrum Antiviral Ivermectin Targets the Host Nuclear Transport Importin \u03b1\/\u03921 Heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin Is a Specific Inhibitor of Importin \u03b1\/\u03b2-Mediated Nuclear Import Able to Inhibit Replication of HIV-1 and Dengue Virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin Is a Potent Inhibitor of Flavivirus Replication Specifically Targeting NS3 Helicase Activity: New Prospects for an Old Drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","article-title":"A Nuclear Transport Inhibitor That Modulates the Unfolded Protein Response and Provides in Vivo Protection against Lethal Dengue Virus Infection","volume":"210","author":"Fraser","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1087057110390360","article-title":"An AlphaScreen\u00ae-Based Assay for High-Throughput Screening for Specific Inhibitors of Nuclear Import","volume":"16","author":"Wagstaff","year":"2011","journal-title":"SLAS Discov."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Atkinson, S.C., Audsley, M.D., Lieu, K.G., Marsh, G.A., Thomas, D.R., Heaton, S.M., Paxman, J.J., Wagstaff, K.M., Buckle, A.M., and Moseley, G.W. (2018). Recognition by Host Nuclear Transport Proteins Drives Disorder-to-Order Transition in Hendra Virus v. Sci. Rep., 8.","DOI":"10.1038\/s41598-017-18742-8"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Yang, S.N.Y., Atkinson, S.C., Fraser, J.E., Wang, C., Maher, B., Roman, N., Forwood, J.K., Wagstaff, K.M., Borg, N.A., and Jans, D.A. (2019). Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin \u03b1\/\u03921 Heterodimer. Cells, 8.","DOI":"10.3390\/cells8030281"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.2022.18590","article-title":"Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial","volume":"328","author":"Naggie","year":"2022","journal-title":"JAMA"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.therap.2022.03.002","article-title":"Adverse Drug Reactions Associated with Ivermectin Use For-19 Reported in the World Organization\u2019s Pharmacovigilance Database","volume":"77","author":"Campillo","year":"2022","journal-title":"Therapies"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","article-title":"Antibodies to Combat Viral Infections: Development Strategies and Progress","volume":"21","author":"Pantaleo","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1658936","article-title":"Antibody-Mediated Clearance of Alphavirus Infection from Neurons","volume":"254","author":"Levine","year":"1991","journal-title":"Science"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymeth.2005.01.003","article-title":"SDR Grafting\u2014A New Approach to Antibody Humanization","volume":"36","author":"Kashmiri","year":"2005","journal-title":"Methods"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1473-3099(24)00030-6","article-title":"An Observer-Blind, Randomised, Placebo-Controlled, Phase 1, Single Ascending Dose Study of Dengue Monoclonal Antibody in Healthy Adults in Australia","volume":"24","author":"Gunale","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/AAC.01285-13","article-title":"A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults","volume":"57","author":"Robbie","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e20210174","DOI":"10.1084\/jem.20210174","article-title":"Broadly Neutralizing Monoclonal Antibodies Protect against Multiple Tick-Borne Flaviviruses","volume":"218","author":"VanBlargan","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","article-title":"Dengue Virus Neutralization by Human Immune Sera: Role of Envelope Protein Domain III-Reactive Antibody","volume":"392","author":"Wahala","year":"2009","journal-title":"Virology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.chom.2020.04.007","article-title":"Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies","volume":"27","author":"Young","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A New Class of Highly Potent, Broadly Neutralizing Antibodies Isolated from Viremic Patients Infected with Dengue Virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1016\/j.cell.2021.11.010","article-title":"The Epitope Arrangement on Flavivirus Particles Contributes to Mab C10\u2019s Extraordinary Neutralization Breadth across Zika and Dengue Viruses","volume":"184","author":"Sharma","year":"2021","journal-title":"Cell"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, Cross-Reactivity, and Function of Antibodies Elicited by Zika Virus Infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural Basis of West Nile Virus Neutralization by a Therapeutic Antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e02861-18","DOI":"10.1128\/mBio.02861-18","article-title":"Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus","volume":"10","author":"Bailey","year":"2019","journal-title":"mBio"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4269\/ajtmh.1989.41.576","article-title":"Monoclonal Antibodies for Dengue Virus PrM Glycoprotein Protect Mice against Lethal Dengue Infection","volume":"41","author":"Kaufman","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a Humanized Monoclonal Antibody with Therapeutic Potential against West Nile Virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41564-018-0283-7","article-title":"A Protective Human Monoclonal Antibody Targeting the West Nile Virus E Protein Preferentially Recognizes Mature Virions","volume":"4","author":"Goo","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing Human Antibodies Prevent Zika Virus Replication and Fetal Disease in Mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cid\/cis883","article-title":"Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines against Circulating Heterologous JE Virus Genotypes","volume":"56","author":"Erra","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A Tick-Borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-Neutralizing Antibodies in Humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"108226","DOI":"10.1016\/j.celrep.2020.108226","article-title":"Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees","volume":"33","author":"Martinez","year":"2020","journal-title":"Cell Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"110930","DOI":"10.1016\/j.celrep.2022.110930","article-title":"Vaccine-Induced Antibodies to Contemporary Strains of Dengue Virus Type 4 Show a Mechanistic Correlate of Protective Immunity","volume":"39","author":"Gallichotte","year":"2022","journal-title":"Cell Rep."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"e147066","DOI":"10.1172\/JCI147066","article-title":"Dengue Vaccine Breakthrough Infections Reveal Properties of Neutralizing Antibodies Linked to Protection","volume":"131","author":"Henein","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"E8378","DOI":"10.1073\/pnas.1714250115","article-title":"Viral Genetic Diversity and Protective Efficacy of a Tetravalent Dengue Vaccine in Two Phase 3 Trials","volume":"115","author":"Juraska","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/JVI.02129-14","article-title":"The Human CD8+ T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J. Virol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e01469-17","DOI":"10.1128\/JVI.01469-17","article-title":"Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J. Virol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e02147-16","DOI":"10.1128\/JVI.02147-16","article-title":"Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity","volume":"91","author":"Angelo","year":"2017","journal-title":"J. Virol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal Antibody-Mediated Enhancement of Dengue Virus Infection in Vitro and in Vivo and Strategies for Prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Li, M., Zhao, L., Zhang, C., Wang, X., Hong, W., Sun, J., Liu, R., Yu, L., Wang, J., and Zhang, F. (2018). Dengue Immune Sera Enhance Zika Virus Infection in Human Peripheral Blood Monocytes through Fc Gamma Receptors. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200478"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"eabg9478","DOI":"10.1126\/scitranslmed.abg9478","article-title":"Dengue and Zika Virus Infections in Children Elicit Cross-Reactive Protective and Enhancing Antibodies That Persist Long Term","volume":"13","author":"Katzelnick","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2019.01.005","article-title":"Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy Provided Critical Reagents and Intellectual Input HHS Public Access","volume":"50","author":"Brown","year":"2019","journal-title":"Immunity"},{"key":"ref_187","first-page":"7239347","article-title":"Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population","volume":"2019","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1128\/JVI.01096-16","article-title":"Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection","volume":"90","author":"Xu","year":"2016","journal-title":"J. Virol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virusres.2008.07.022","article-title":"Characterization of the Interaction of Domain III of the Envelope Protein of Dengue Virus with Putative Receptors from CHO Cells","volume":"137","author":"Huerta","year":"2008","journal-title":"Virus Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.chom.2023.10.004","article-title":"Homotypic Antibodies Target Novel E Glycoprotein Domains after Natural DENV 3 Infection\/Vaccination","volume":"31","author":"Munt","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"e00818-23","DOI":"10.1128\/mbio.00818-23","article-title":"Dengue Virus 4\/2 Envelope Domain Chimeric Virus Panel Maps Type-Specific Responses against Dengue Serotype 2","volume":"14","author":"Zhu","year":"2023","journal-title":"mBio"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J. Virol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1473-3099(24)00099-9","article-title":"Effect of Single-Dose, Live, Attenuated Dengue Vaccine in Children with or without Previous Dengue on Risk of Subsequent, Virologically Confirmed Dengue in Cebu, the Philippines: A Longitudinal, Prospective, Population-Based Cohort Study","volume":"24","author":"Ylade","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_196","unstructured":"World Health Organization (2016). Weekly Epidemiological Record, World Health Organization."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.mayocp.2019.05.016","article-title":"Zika Vaccine Development: Current Status","volume":"94","author":"Poland","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ajog.2019.06.013","article-title":"The Fetal Origins of Mental Illness","volume":"221","author":"Oler","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_199","first-page":"237","article-title":"Rapid Development of a DNA Vaccine for Zika Virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science (1979)"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, Tolerability, and Immunogenicity of Two Zika Virus DNA Vaccine Candidates in Healthy Adults: Randomised, Open-Label, Phase 1 Clinical Trials","volume":"391","author":"Ramanathan","year":"2018","journal-title":"Lancet"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Kozak, M., and Hu, J. (2024). DNA Vaccines: Their Formulations, Engineering and Delivery. Vaccines, 12.","DOI":"10.3390\/vaccines12010071"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika Virus Protection by a Single Low-Dose Nucleoside-Modified MRNA Vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"ref_203","first-page":"221","article-title":"Equine Vaccine for West Nile Virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev. Biol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vetimm.2008.02.002","article-title":"A West Nile Virus (WNV) Recombinant Canarypox Virus Vaccine Elicits WNV-Specific Neutralizing Antibodies and Cell-Mediated Immune Responses in the Horse","volume":"123","author":"Minke","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archinte.166.10.1121","article-title":"Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons","volume":"166","author":"Keitel","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Danet, L., Beauclair, G., Berthet, M., Moratorio, G., Gracias, S., Tangy, F., Choumet, V., and Jouvenet, N. (2019). Midgut Barriers Prevent the Replication and Dissemination of the Yellow Fever Vaccine in Aedes Aegypti. PLoS Negl. Trop. Dis., 13.","DOI":"10.1101\/577213"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biologicals.2019.06.001","article-title":"Evaluation of Environment Safety of a Japanese Encephalitis Live Attenuated Vaccine","volume":"60","author":"Liu","year":"2019","journal-title":"Biologicals"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A Live, Attenuated Recombinant West Nile Virus Vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.vaccine.2012.08.063","article-title":"Phase II, Dose Ranging Study of the Safety and Immunogenicity of Single Dose West Nile Vaccine in Healthy Adults \u2265 50 Years of Age","volume":"30","author":"Dayan","year":"2012","journal-title":"Vaccine"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1016\/j.vaccine.2013.07.064","article-title":"The Live Attenuated Chimeric Vaccine RWN\/DEN4\u039430 Is Well-Tolerated and Immunogenic in Healthy Flavivirus-Na\u00efve Adult Volunteers","volume":"31","author":"Durbin","year":"2013","journal-title":"Vaccine"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1016\/j.vaccine.2018.12.026","article-title":"An Observer Blinded, Randomized, Placebo-Controlled, Phase I Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001, in Healthy Adults","volume":"37","author":"Woods","year":"2019","journal-title":"Vaccine"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/infdis\/jir054","article-title":"A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial","volume":"203","author":"Ledgerwood","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1297-9716-43-16","article-title":"Recent Progress in West Nile Virus Diagnosis and Vaccination","volume":"43","author":"Ulbert","year":"2012","journal-title":"Vet. Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-Borne Encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese Encephalitis the Virus and Vacci","volume":"10","author":"Yun","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1016\/j.vaccine.2017.03.032","article-title":"Yellow Fever Live Attenuated Vaccine: A Very Successful Live Attenuated Vaccine but Still We Have Problems Controlling the Disease","volume":"35","author":"Barrett","year":"2017","journal-title":"Vaccine"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Wollner, C.J., and Richner, J.M. (2021). MRNA Vaccines against Flaviviruses. Vaccines, 9.","DOI":"10.3390\/vaccines9020148"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nchem.2236","article-title":"Functionalization of Cobalt Porphyrin-Phospholipid Bilayers with His-Tagged Ligands and Antigens","volume":"7","author":"Shao","year":"2015","journal-title":"Nat. Chem."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coviro.2020.07.006","article-title":"Mapping the Diverse Structural Landscape of the Flavivirus Antibody Repertoire","volume":"45","author":"Sevvana","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition Determinants of Broadly Neutralizing Human Antibodies against Dengue Viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"eabg4084","DOI":"10.1126\/sciadv.abg4084","article-title":"Designed, Highly Expressing, Thermostable Dengue Virus 2 Envelope Protein Dimers Elicit Quaternary Epitope Antibodies","volume":"7","author":"Kudlacek","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of Human Neutralizing Antibodies That Bind to Complex Epitopes on Dengue Virions","volume":"109","author":"Smith","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1080\/21645515.2018.1546523","article-title":"Immunogenicity and Safety of an Investigational Tetravalent Recombinant Subunit Vaccine for Dengue: Results of a Phase I Randomized Clinical Trial in Flavivirus-Na\u00efve Adults","volume":"15","author":"Manoff","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1016\/j.vaccine.2011.07.021","article-title":"The Development of Recombinant Subunit Envelope-Based Vaccines to Protect against Dengue Virus Induced Disease","volume":"29","author":"Coller","year":"2011","journal-title":"Vaccine"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and Structures of a Rationally Designed Prefusion MERS-CoV Spike Antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e57659","DOI":"10.7554\/eLife.57659","article-title":"Tailored Design of Protein Nanoparticle Scaffolds for Multivalent Presentation of Viral Glycoprotein Antigens","volume":"9","author":"Ueda","year":"2020","journal-title":"eLife"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41467-023-41661-4","article-title":"Nanoparticle Display of Prefusion Coronavirus Spike Elicits S1-Focused Cross-Reactive Antibody Response against Diverse Coronavirus Subgenera","volume":"14","author":"Hutchinson","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Phan, T.T.N., Hvasta, M.G., Kudlacek, S.T., Thiono, D.J., Tripathy, A., Nicely, N.I., de Silva, A.M., and Kuhlman, B. (2022). A Conserved Set of Mutations for Stabilizing Soluble Envelope Protein Dimers from Dengue and Zika Viruses to Advance the Development of Subunit Vaccines. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2022.102079"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1038\/ncomms15411","article-title":"Covalently Linked Dengue Virus Envelope Glycoprotein Dimers Reduce Exposure of the Immunodominant Fusion Loop Epitope","volume":"8","author":"Rouvinski","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","article-title":"A Protective Zika Virus E-Dimer-Based Subunit Vaccine Engineered to Abrogate Antibody-Dependent Enhancement of Dengue Infection","volume":"20","author":"Dejnirattisai","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"RP87555","DOI":"10.7554\/eLife.87555.3","article-title":"Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop","volume":"12","author":"Meganck","year":"2023","journal-title":"eLife"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ddtec.2021.02.001","article-title":"Gold Nanoparticle-Based Platforms for Vaccine Development","volume":"38","author":"Lay","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"122331","DOI":"10.1016\/j.lfs.2023.122331","article-title":"Vaccine Development: Current Trends and Technologies","volume":"336","author":"Poria","year":"2024","journal-title":"Life Sci."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified MRNA Vaccines Protect against Zika Virus Infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/1\/1\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:58:53Z","timestamp":1760115533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/1\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["v17010001"],"URL":"https:\/\/doi.org\/10.3390\/v17010001","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]}}}